Authors' response to a reply to 'A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients'.

Br J Dermatol

Dermatology and Bosch Institute, University of Sydney at Royal Prince Alfred Hospital, Camperdown, Australia.

Published: February 2017

Download full-text PDF	Source
http://dx.doi.org/10.1111/bjd.15204	DOI Listing

Publication Analysis

authors' response

response reply

reply phase

phase randomized

randomized controlled

controlled trial

trial nicotinamide

nicotinamide skin

skin cancer

cancer chemoprevention

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!